Elanco Animal Health (ELAN) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Total Assets Chart for Elanco Animal Health

Elanco Animal Health (ELAN) total assets for FY2025 were USD 13.4B, a 5.9% change from FY2024. Elanco Animal Health's total assets grew from USD 8.1B in 2016 to USD 13.4B in 2025 (64.9% over 9 years). Total assets compound annual growth rate: 5-year CAGR of -5.5%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (US Dollars)

R&D as % of Revenue

Key Stats

Market Cap
$11.17B
Implied Share Price
$22.36
Enterprise Value
$14.66B
Revenue (TTM)
$5.02B
EBITDA
$1.01B
Profit Margin
-3.96%
Trailing P/E
—
Forward P/E
17.36
Price/Book (MRQ)
1.71
Price/Sales (TTM)
2.23
EV/EBITDA
18.92
EV/Revenue
2.92
Dividend Yield
—
Book Value
$13.19
Free Cash Flow (FY2025)
$284.00M
Free Cash Flow Yield
2.54%

Snapshot as of 7th October 2026 — not point-in-time controlled, may lag the live market by a few days.